Latest news

Journal newsletter sent to subscribers in week 37, 2009. Follow link to see newsletter summary.  Register to receive newsletters.   

Journal newsletter sent to subscribers in week 34, 2009. Register to receive future newsletters. 

Journal newsletter sent to subscribers in week 32, 2009. Register to receive future newsletters.

Read the Editor in Chief's latest call for papers here.

Journal newsletter sent to subscribers in week 12, 2009.  Register to receive future newsletters.

Journal newsletter sent to subscribers in week 11, 2009.  Register to receive future newsletters.

New call for papers sent to newsletter subscribers in week 10 2009.  Readers who wish to be elligible to receive CFPs should subscribe to the newsletter.

Journal newsletter sent to subscribers in week 8, 2009. Register to receive future newsletters. 

Peer reviewers are sought. Click here to apply or to update your details.

Journal overview

Immunology and Immunogenetic Insights is a peer-reviewed, open access journal that covers all aspects of the study of the immune system in all organisms. It encompasses pathophysiology and physiology in health, immunological disorders including immunodeficiency, and characteristics in vitro, in vivo and in situ. As such, it also includes applications in a clinical environment, immunotherapy, diagnostic immunology, evolutionary immunology, and areas of study such as immunogenetics. Technologies, models and bioinformatics related to this field of study are also relevant.

Indexing:

This journal is indexed by:

• Directory of Open Access Journals
  
• OAIster
  

Editorial standards and procedures:

Submissions, excluding editorials, letters to the editor and dedications, will be peer reviewed by two reviewers.  Reviewers are required to provide fair, balanced and constructive reports.  

Under our Fairness in Peer Review Policy authors may appeal against reviewers' recommendations which are ill-founded, unobjective or unfair.  Appeals are considered by the Editor in Chief or Associate Editor.

Papers are not sent to peer reviewers following submission of a revised manuscript. Editorial decisions on re-submitted papers are based on the author's response to the initial peer review report.

National Institutes of Health Public Access Policy compliant:

As of April 7 2008, the US NIH Public Access Policy requires that all peer reviewed articles resulting from research carried out with NIH funding be deposited in the Pubmed Central archive.

If you are an NIH employee or grantee Libertas Academica will ensure that you comply with the policy by depositing your paper at Pubmed Central on your behalf. 

Information for authors

Call for papers:

Read the Editor in Chief's latest call for papers here.

Submission types accepted:

• Original research articles.
• Reviews: comprehensive, authoritative, descriptions of any subject within the journal's scope. They may cover basic science and clinical reviews, ethics, pro/con debates, and equipment reviews.
• Commentaries: focused and opinionated articles on any subject within the journal's scope. These articles are usually related to a contemporary issue.
• Hypotheses: articles that present an original hypothesis backed solely by previously published results rather than any new evidence. They should outline significant progress in thinking that would also be testable.
• Letters to the Editor: these can be either a re-analysis of a previously published article, or a response to such a re-analysis from the authors of the original publication.
• Methodology articles: these discuss a new experimental method, test or procedure. The article must describe a demonstrable advance on what is currently available. The method needs to have been well tested and ideally, but not necessarily, used in a way that proves its value.
• Short reports: brief reports of data from original research.
• Meeting reports: a report pertaining to activity at a meeting or conference Articles published in this journal are immediately available without delay upon publication and enjoy substantial visibility.
• Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction. Case reports must meet appropriate ethical standards.

All submissions are subject to prompt, objective and fair peer review in compliance with our Fairness in Peer Review Policy.  Copyright in published articles remains with the author(s).  Authors are continually informed of the progress of their paper and our staff are friendly and responsive. 

One author recently wrote: "I would like to say that this is the most author-friendly editing process I have experienced in over 150 publications. Thank you most sincerely."

Criteria for publication: 

Publication is dependent on peer reviewers' judgement of papers.  Reviewers are asked to provide thoughtful and unbiased feedback to authors to ensure that the conclusions of papers are valid and manuscripts achieve reasonable standards of scholarliness and intelligibility. 

Previous work in the field must be acknowledged and papers should read without unreasonable difficulty.  Papers should fit comfortably within the scope of the journal.

Reviewers are asked to act in a fair, objective and constructive manner which maintains quality standards and helps authors to communicate their research.  They are instructed that in areas of genuinely novel research issues may be raised which cannot immediately be resolved and that absolutely rigorous validation of data may therefore not be possible. 

More information on the role of peer reviewers is available on the information for reviewers page.  Where authors consider that reviewers have made recommendations which are unreasonable, unobjective or ill-founded they may appeal them to the Editor in Chief or Associate Editor under our Fairness in Peer Review Policy.

Articles submitted to other journals:

We are willing to consider papers which have been peer reviewed by other journals but not accepted for publication. 

Services for authors:

Prior to peer review of your paper we can:

• Have your paper's reference style revised to meet our requirements,
• Have your paper's English revised by specialist English-speaking technical editors.

After peer review of your paper we can:

• Have your paper revised in accordance with peer reviewer's recommendations and have a summary of responses to the reviewers created by our specialist external substantive editors,
• Provide bound reprints of your article in colour or black and white ,
• Provide online-early rapid publication if your paper prior to typesetting.

What other authors have said:

Libertas Academica actively requests, receives and acts upon feedback from authors, readers and editorial boards.  Here's what some recent authors have said about us:

"Within a couple of days the reviewers had been procured and the manuscript was out."

"The communication between your staff and me has been terrific.  Whenever progress is made with the manuscript, I receive notice.  Quite honestly, I've never had such complete communication with a journal."

"LA is different, and hopefully represents a kind of scientific publication machinery that removes the hurdles from free flow of scientific thought."

Article processing fees:

All submissions to this journal are subject to an article processing fee if they are accepted for publication.  Article processing fees are used to fund the processing of your paper and development of the journal.  Article processing fees are the only compulsory charge you will face and do not vary according to word count, page count, colour figures or any other factor.  There is no additional charge for the author(s) to make any use of their article and no charge to readers to access it.

Full fee waivers are available for authors working in undeveloped nations and partial discounts of 20-50% are available to authors in other nations.  Authors must be able to verifiably demonstrate their suitability for a discount or waiver.  Availability of waivers and discounts is subject to monthly availability and is given at the publisher's discretion.  Waivers and discounts must be applied for prior to submission.  Neither are available after submission.

Register as a peer reviewer:

Do you wish to register as a peer reviewer?  Or are you already a registered peer reviewer but you need to update your contact details?   To register or update your details visit the peer reviewer registration form. 

Applicants must be able to demonstrate at least five years of continuous experience in the journal's subject area including at least two in the previous 24 months.

Editor in Chief profile

Dr Darren R Flower is an independent Jenner Fellow working at the Jenner Institute, part of the University of Oxford. Previously he was Senior Group Leader at the Edward Jenner Institute for Vaccine Research and before that a Drug Discovery Scientist at Astra Charnwood, now AstraZeneca. He is Chairman of Royal Society of Chemistry’s Molecular Modelling Group and a Fellow of Royal Society of Chemistry. He is also a member of the International Immunomics Society, the Medical Research Council College of Experts, and the RSC Chemical Biology Forum Executive committee. Dr Flower has published over 110 papers and 4 books, and is one of BioMed Central’s HOT 100 authors 2006 and 2007. He sits on 9 Editorial Boards including the Biochemical Journal and Immunomics Research, and is widely consulted as a reviewer. He has extensive experience of organizing national and internation meetings and conferences. Dr Flower has wide scientific interests with a special focus on Immunology and Vaccine discovery.

>> Dr Flower's latest call for papers

Editorial Board

Anoop Ivan Benjamin, MBBS DNB MPH
Professor, Department of Community Medicine, Christian Medical College, Ludhiana, Punjab, India

Hugo Antonius van den Berg, PhD
Mathematics Institute, Warwick Systems Biology Center, University of Warwick, Coventry, UK

Frank Buttgereit, MD
Professor, Department of Rheumatology and Clinical Immunology, Charité University Medicine Berlin, Berlin, Germany

Kung-Chao Chang, MD
Assistant Professor, Department of Pathology, National Cheng Kung University, Tainan, Taiwan

Kenneth R. Chapman, MD MSc FRCPC FACP FCCP
Professor of Medicine, University of Toronto; and Director, Asthma & Airway Centre, University Health Network, Toronto, Ontario, Canada

Geoffrey Lowell Chupp, MD
Director, Yale Center for Asthma and Airway Diseases, Division of Pulmonary and Critical Care Medicine; Associate Professor of Medicine, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA

Marcelo Eduardo Corti, MD
Assistant Professor of Infectious Diseases, Faculty of Medicine, University of Buenos Aires; and Chief of HIV/AIDS Division, Infectious Diseases Department, F. J. Muñiz Hospital, Buenos Aires, Argentina

Russell C. Dale, MBChB MRCPCH MSc PhD
Senior Lecturer, Neuroinflammation Group, Discipline of Paediatrics and Child Health, Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia

Ignacio J. Dávila, MD PhD
Assistant Professor of Allergy, Allergy Service, University Hospital, Salamanca, Spain

Eva Rebelo Gomes, MD
Drug Hypersensitivity Clinic, Allergy and Clinical Immunology Department, Centro Hospitalar do Porto, Unidade Hospital Maria Pia, Porto, Portugal

Paul Gorry, PhD
Associate Professor, HIV Molecular Pathogenesis Laboratory, Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Victoria, Australia

Gabriela Gualco, MD PhD
Pathology Department , Consultoria em Patologia, Botucatu, Saõ Paulo, Brazil

Zeev Theodor Handzel, MD FAAAAI
Emeritus Associate Professor of Pediatrics and Clinical Immunology, Pediatric Research Institute, Kaplan Medical Center, Rehovot, Israel

Hans Jürgen Hoffmann, PhD
Associate Professor, Department of Respiratory Diseases, The Clinical Institute, Aarhus University Hospital, Aarhus University, Aarhus, Denmark

John Carl Hornberger, MD MS
Adjunct Clinical Professor of Medicine, Department of Medicine, Division of General Internal Medicine, Stanford University School of Medicine, Stanford University, Stanford, California, USA

John Idoko, MD
Professor, Department of Medicine, University of Jos, Jos, Plateau State, Nigeria

Chaim Oscar Jacob, MD PhD
Professor of Medicine, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA

Dieter Kabelitz, MD
Professor & Institute Director, Institute of Immunology, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany

Tsuyoshi Kasama, MD PhD
Associate Professor, Division of Rheumatology, Department of Internal Medicine, Showa University School of Medicine, Tokyo, Japan

Edward C. Keystone, MD FRCP
Professor of Medicine, University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada

Bette Korber, PhD
Laboratory Fellow, Theoretical Biology, Los Alamos National Laboratory, Los Alamos, New Mexico, USA

Lin-Feng Li, MD PhD
Professor, Department of Dermatology, Peking University Third Hospital, Beijing, P.R. China

Ian Reay Mackay, MD
Professor, Department of Biochemistry and Molecular Biology, School of Biological Sciences, Faculty of Medicine, Monash University, Clayton, Victoria, Australia

Arvind Madaan, MD, MBBS
Consultant, Allergy and Immunology, Danville Ent, Lynchburg, VA, USA

Nizar Mahlaoui, MD
Unité d'Immuno-Hématologie et Rhumatologie pédiatriques, Centre de Référence Déficits Immunitaires Héréditaires (CEREDIH), Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France

Markus Y. Mapara, MD PhD
Associate Professor of Medicine, Department of Medicine, University of Pittsburgh; and Scientific Director, Hematopoietic Stem Cell Transplantation Program, Hillman Cancer Center, Pittsburgh, Philadelphia, USA

Steven G.E. Marsh, PhD
Anthony Nolan Research Institute, Royal Free Hospital, London, UK

William Matsui, MD
Assistant Professor, Division of Hematologic Malignancies, Department of Oncology, Johns Hopkins University School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA

Derek L Mattey, PhD
Department of Rheumatology, University Hospital of North Staffordshire / Keele University, Stoke-on-Trent, UK

Sara Miri, MD
Postdoctoral Fellow, Department of Surgery, University of Washington, Seattle, Washington, USA

Edith P. Mitchell, MD FACP
Clinical Professor of Medicine and Medical Oncology; Program Leader, Gastrointestinal Oncology, Department of Medical Oncology; Associate Director of Diversity Programs, Kimmel Cancer Center at Jefferson, Thomas Jefferson University, Philadelphia, Pennsylvania, USA

Chi Chiu Mok, MD FRCP
Director, Center for Assessment and Treatment of Rheumatic Diseases, Department of Medicine, Tuen Mun and Pok Oi Hospital, New Territories, Hong Kong, SAR China

M.J. Molina-Garrido, PhD
Physician, Oncology Department, General Universitary Hospital in Elche, Elche-Alicante, Spain

Shigeki Momohara, MD PhD
Professor, Department of Orthopaedic Surgery, Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan

Felix Mor, MD PhD
Professor, Department of Immunology, Weizmann Institute of Science, Rehovot; Department of Medicine B, Rabin Medical Center and Felsenstein Medical Research Center, Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Israel

Ralph Mösges, MD PhD MSEE
Institut für Medizinische Statistik, Informatik und Epidemiologie (IMSIE) / Institute of Medical Statistics, Informatics and Epidemiology, Universität zu Köln / University of Cologne, Cologne, North Rhine-Westphalia, Germany

Masaaki Niino, MD PhD
Assistant Professor, Department of Neurology, Hokkaido University Hospital, Sapporo, Japan

Norihiro Nishimoto, MD PhD
Professor, Laboratory of Immune Regulation, Graduate School of Frontier Biosciences, Osaka University, Suita City, Osaka, Japan

Blanca Cárdaba Olombrada, PhD
Biological Scientist, Immunology Department, Fundación Jiménez Díaz, Madrid, Spain

Terry M. Phillips, PhD DSc
Chief, Nanoscale Immunodiagnostics Section, Laboratory of Bioengineering & Physical Science, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland, USA

Silvia S. Pierangeli, PhD
Professor, Division of Rheumatology/Department of Internal Medicine, Department of Microbiology, Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA

Hans-Georg Rammensee, PhD
Professor, Interfakultäres Institut für Zellbiologie Abt. Immunologie Auf der Morgenstelle 15, Tübingen, Germany

Manuel Ramos-Casals, MD PhD
Specialist, Laboratory of Autoimmune Diseases “Josep Font”, Department of Autoimmune Diseases, IDIBAPS, Hospital Clinic, Barcelona, Spain

Pedro A. Reche, PhD
Ramon y Cajal Scientist and Professor of Immunology, Department of Microbiology I, Division of Immunology, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Madrid, Spain

Shinichi Sato, MD PhD
Professor, Department of Dermatology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan

Giuseppe Alessandro Scardina, PhD
Researcher, Department of Oral Sciences, University of Palermo, Palermo, Italy

Leonard H. Sigal, MD
Clinical Professor, Departments of Medicine and Pediatrics, Division of Rheumatology (ex-Chief of Division), University of Medicine and Dentistry of New Jersey- Robert Wood Johnson Medical School, New Brunswick, New Jersey; and Director, Immunology, Research and Development, Bristol-Myers Squibb, Princeton, New Jersey, USA

Menaka Soory, FDSRCS PhD FHEA
Professor, Periodontology Department, King's College London Dental Institute at GKT Hospitals, King's College Dental Hospital, London, UK

Souvenir Tachado, MD
Instructor in Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

James Temprano, MD MHA
Assistant Professor, Department of Internal Medicine, Division of Allergy and Immunology, University of Kentucky; and Division of Allergy and Immunology, Kentucky Clinic, Lexington, Kentucky, USA

Giovanni Tonon, MD PhD
Instructor in Medicine, Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA

Robert Yarchoan, MD
Branch Chief, HIV and AIDS Malignancy Branch, Centre for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA

Join an editorial board or update your details:

Related journals